DSM completes Cargill business acquisition

by Editor fleischwirtschaft.com
Thursday, December 13, 2012

Royal DSM said it had completed its acquisition of Cargill's cultures and enzymes business, which should boost DSM's growth plans for its food business.

DSM's portfolio of ingredients now includes enzymes, polyunsaturated fatty acids, vitamins, cultures, probiotics and bio actives. DSM on Oct. 26 originally announced it had agreed to buy the Cargill business in an all cash transaction for €85 mill.

Cargill's cultures and enzymes operation also forms part of the company's global texturising business and employs roughly 200 people. The cultures and enzymes business has production facilities in Wisconsin, USA, and La Ferte-Sous-Jouarre, France. The market for cultures and enzymes is valued at more than €1 bill., growing steadily at more than 5% annually.